Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Testis expressed transcript, Y-linked 2B (TTTY2B) is a long non-coding RNA gene located on the human Y chromosome and is predominantly expressed in testicular tissue, especially in male germline stem cells[1][2][6][7]. This gene does not code for a protein but is classified as a testis-specific transcript[2][6][7]. The broader TTTY2 gene family, which includes TTTY2B, has been implicated in male reproductive biology, and deletions have been studied for possible links to male infertility, though its exact function and disease mechanisms are not well-defined[9][5]. There are no approved drugs targeting this gene, nor is it established as a direct therapeutic target, biomarker, or source of major safety concerns[6][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Testis expressed transcript, Y-linked 2B (TTTY2B).